Drug
D0139 | Daidzein
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ELECTRON TRANSPORT CHAIN | 127 μM | rat | brain MF0F1-ATPase | decrease | IC50 | 151 | ||
| Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| ATP synthase | 127 μM | rat | brain MF0F1-ATPase | inhibitor | IC50 | 151 | ||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 53 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. Reported as not meeting GHS hazard criteria by 3 of 53 companies. For more detailed information, please visit ECHA C&L website Of the 4 notification(s) provided by 50 of 53 companies with hazard statement code(s): H315 (98%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (98%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 220930-96-1 | 4 inverted exclamation marka,7-Dihydroxyisoflavone | 4′,7-Dihydroxyisoflavone |
| 4',7-Dihydroxy-iso-flavone | 4',7-Dihydroxyisoflavone | 4',7-Dihydroxyisoflavone, 97% |
| 4',7-dihydroxy isoflavone | 4',7-dihydroxy-Isoflavone | 4,7-Dihydroxyisoflavone |
| 486-66-8 | 486D668 | 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)- |
| 5-18-04-00089 (Beilstein Handbook Reference) | 6287WC5J2L | 7,4'-Dihydroxy-isoflavone (3a) |
| 7,4'-Dihydroxyisoflavone | 7-HYDROXY-3-(4-HYDROXYPHENYL)CHROMONE | 7-Hydroxy-3-(4-hydroxy-phenyl)-4H-1-benzo-pyran-4-one |
| 7-Hydroxy-3-(4-hydroxy-phenyl)-chromen-4-one | 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone | 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone |
| 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | 7-Hydroxy-3-(4-hydroxyphenyl)chromone |
| 7-hydroxy-3-(4-hydroxyphenyl)-4H- | 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one | 7-hydroxy-3-(4-hydroxyphenyl)-chromen-4-one |
| 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one | 80E3ED75-D852-4D97-9BD6-B5ADE7EA25A1 | AB00052712-08 |
| AB00052712_10 | AB0010476 | AB1004493 |
| AC-6035 | ACN-034764 | ACon0_001477 |
| ACon1_000543 | AK-94232 | AKOS002385052 |
| ALBB-015933 | AOB5524 | BB 0259520 |
| BBL010490 | BCP28286 | BDBM23420 |
| BIDD:ER0120 | BIMB2005 | BMK1-F12 |
| BRD-K42095107-001-02-3 | BRD-K42095107-001-05-6 | BRD-K42095107-001-08-0 |
| BRN 0231523 | BS0244 | BSPBio_001741 |
| BiomolKI2_000066 | BiomolKI_000060 | C-15745 |
| C10208 | CAS-486-66-8 | CC-17424 |
| CCG-38357 | CCRIS 7600 | CD-190 |
| CHEBI:28197 | CHEMBL8145 | CS-2332 |
| Certified Reference Material | D 7802 | D2668 |
| DB13182 | DSSTox_CID_2310 | DSSTox_GSID_22310 |
| DSSTox_RID_76543 | DTXSID9022310 | Daidzein (4',7-Dihydroxyisoflavone) |
| Daidzein (6CI) | Daidzein, 98% | Daidzein, >=98%, synthetic |
| Daidzein, Pharmaceutical Secondary Standard | Daidzein, United States Pharmacopeia (USP) Reference Standard | Daidzein, analytical standard |
| Daidzein, primary pharmaceutical reference standard | Daidzein, purum, >=98.0% (TLC) | Daidzein,(S) |
| Daidzeol | Diadzein | DivK1c_001023 |
| EINECS 207-635-4 | EU-0100412 | FT-0080019 |
| FT-0603419 | FT-0665448 | GTPL2828 |
| HMS1922P18 | HMS2233H24 | HMS3261C06 |
| HMS3267J04 | HMS3370C03 | HMS3412O12 |
| HMS3468L18 | HMS3649B20 | HMS3655A18 |
| HMS3676O12 | HMS503M07 | HY-N0019 |
| IDI1_001023 | Isoflavone, 4',7-dihydroxy- | Isoflavone, 4',7-dihydroxy- (8CI) |
| K 251b | K-251b | KBio1_001023 |
| KBio2_000735 | KBio2_003303 | KBio2_005871 |
| KBio3_001241 | KBioGR_002432 | KBioSS_000735 |
| KS-00000MGD | KS-5260 | LMPK12050038 |
| LP00412 | LS-2143 | Lopac-D-7802 |
| Lopac0_000412 | MCULE-8239511422 | MEGxm0_000123 |
| MFCD00016954 | MLS000859973 | MLS001304056 |
| MLS006011853 | N1862 | NCGC00015365-01 |
| NCGC00015365-02 | NCGC00015365-03 | NCGC00015365-04 |
| NCGC00015365-05 | NCGC00015365-06 | NCGC00015365-07 |
| NCGC00015365-08 | NCGC00015365-09 | NCGC00015365-10 |
| NCGC00015365-11 | NCGC00015365-12 | NCGC00015365-13 |
| NCGC00015365-14 | NCGC00015365-15 | NCGC00015365-16 |
| NCGC00015365-17 | NCGC00015365-18 | NCGC00025156-01 |
| NCGC00025156-02 | NCGC00025156-03 | NCGC00025156-04 |
| NCGC00025156-05 | NCGC00025156-06 | NCGC00025156-07 |
| NCGC00025156-08 | NCGC00025156-09 | NCGC00025156-10 |
| NCGC00168978-01 | NCGC00168978-02 | NCGC00257367-01 |
| NCGC00258995-01 | NCGC00261097-01 | NINDS_001023 |
| NPI 031E | NPI-031E | OR1035T |
| Oprea1_182317 | Oprea1_305345 | PubChem9841 |
| Q-200924 | Q408732 | R1341 |
| S00273 | SBB066056 | SC-46504 |
| SCHEMBL19814 | SDCCGMLS-0066422.P001 | SDCCGSBI-0050397.P003 |
| SMP1_000089 | SMR000326832 | SPBio_000205 |
| SPECTRUM200789 | SR-01000075492 | SR-01000075492-1 |
| SR-01000075492-12 | SR-01000075492-3 | SR-01000075492-7 |
| SR-01000075492-8 | ST057515 | STK801626 |
| SW218107-2 | Spectrum2_000053 | Spectrum3_000191 |
| Spectrum4_001964 | Spectrum5_000857 | Spectrum_000255 |
| Tocris-1417 | Tox21_201444 | Tox21_303650 |
| Tox21_500412 | UNII-6287WC5J2L | UNII-71B37NR06D component ZQSIJRDFPHDXIC-UHFFFAOYSA-N |
| UPCMLD-DP052 | UPCMLD-DP052:001 | US8552057, 7 |
| ZINC18847034 | ZQSIJRDFPHDXIC-UHFFFAOYSA-N | ZX-AFC000144 |
| ZX-AN014640 | ZX-AT022124 | d-(+)-alpha-methylbenzyl amine |
| d-(+)-alpha-methylbenzylamine | daidzein | s1849 |